Jennie Jeong

Jennie Jeong has extensive work experience in the field of genomics and molecular diagnostics. Jennie is currently working as a Senior Scientist at GRAIL, Inc., focusing on IVD product development. Prior to this, they worked as a Senior Scientist in R&D at Natera from 2020 to 2021.

In 2019, Jennie was a Senior Scientist at HTG Molecular Diagnostics, where they were a member of a specialized team developing an NGS-based assay for breast cancer. Jennie conducted technical feasibility studies, optimized assay chemistry, and collaborated with cross-functional teams.

From 2016 to 2019, they worked at Genomic Health in various roles. As a Senior Scientist, they led the development of an IVD version of the Oncotype DX Genomic Prostate Score test and coordinated experiments on the Biocartis' Idylla cartridge platform. Jennie also played a key role in the preparation and validation of the Oncotype SEQ Liquid Select panel, a blood-based NGS liquid biopsy mutation panel.

Jennie started their career at Genomic Health in 2002, where they held positions as a Scientist in Genomic Sciences and as an Associate Research Scientist in R&D.

Before joining Genomic Health, they worked at Aclara Biosciences Inc. as a Research Associate, focusing on PCR amplification and optimization.

Jennie began their career at AFFYMAX Research Institute as a Research Assistant, where they gained experience in PCR, DNA sequencing, and gene cloning.

Jennie Jeong's work experience demonstrates their expertise in genomics, molecular diagnostics, assay development, and collaboration in cross-functional teams.

Jennie Jeong holds a Bachelor's degree in Biology/Biological Sciences, General from the University of Texas at Austin. The exact duration of their education at this institution is not mentioned.